Microbot Medical
MBOT | NASDAQ
$0.64
-$0.34 (-34.61%)
At close: Nov 16, 2026, 4:00 PM ET
$0.66
+$0.02 (+2.63%)
After-hours:
Nov 16, 2026, 7:58 PM ET
-34.61%
(1D)No price chart data available for 1D timeframe.
Rating
43.8
-1.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #428/1021 (Top 42%)
Key Statistics
Market Data
Market Cap $43.28M
1D Range
0.52 0.66
52W Range
0.52 2.85
Valuation (TTM)
PE -2.37
PB 0.68
EV/EBITDA 0.92
Valuation (NTM)
Forward PE 15.27
Forward PEG 0.17
Price Target $2.50
Cash Flow
FCF Yield -45.3%
SBC Adj. FCF Yield -48.2%
SBC Impact -6.4%
Margins
Gross Margin -398.1%
Operating Margin -5057.4%
FCF Margin -4688.3%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
100.0%
Dil EPS 3Y | 5Y 50.0% |
42.9%
FCF 3Y | 5Y -40.3% |
-13.8%
Returns
ROA -17.8%
ROE -17.1%
ROIC -32.9%
Financial Health
Net Cash
$61.32M
Current Ratio 15.70
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specif...
Sector Healthcare
Industry Medical - Devices
Employees 43
IPO Date Mar 25, 1992
Website www.microbotmedical.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 13, 2026
EPS
-$0.09
Miss -9.09%
YoY:
-28.57% REV
$72K
Beat +747.06%
Next Earnings
Mar 25, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$2.50
Upside
+290.63%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove MBOT